Quantcast
Last updated on April 25, 2014 at 1:22 EDT

Latest Brachytherapy Stories

2014-03-06 23:24:30

Cianna Medical, Inc: Results could expand treatment options for more women with early-stage breast cancer. Aliso Viejo, CA (PRWEB) March 06, 2014 Cianna Medical, Inc., a women’s health company, today announced favorably low recurrence rates – even for younger women – as part of a retrospective analysis of 673 patients with invasive breast cancer treated with the SAVI® breast brachytherapy applicator. SAVI is a strut-based device that delivers a form of accelerated partial...

2014-03-05 08:30:26

Patient-friendly treatment helps minimize radiation exposure to healthy tissues LOS GATOS, Calif., March 5, 2014 /PRNewswire/ -- On January 14, a 67-year-old male patient received his final Esteya® electronic brachytherapy session to treat a squamous cell carcinoma on his right hand. He was the first patient in the United States to receive Esteya treatment, which was delivered at a Los Gatos, California clinic by Rakesh Patel, MD, Medical Director at The Targeted Radiation Institute...

2014-02-27 20:23:01

Myanmar's Vice President and Minister of Health attend grand opening event showcasing new radiotherapy and brachytherapy systems YANGON, Myanmar, Feb. 27, 2014 /PRNewswire/ -- Yangon General Hospital has become the first clinical site in Myanmar to install new technology from Varian Medical Systems (NYSE: VAR) for treating cancer with radiotherapy. Earlier this month, the hospital unveiled its new medical linear accelerator plus technology for high-dose-rate brachytherapy at a Grand Opening...

2014-02-22 00:20:49

KENNEWICK, Wash., Feb. 21, 2014 /PRNewswire/ -- Advanced Medical Isotope Corporation ("AMIC") (OTCBB: ADMD), a company engaged in the development, production and distribution of medical isotopes focused on yttrium-90 brachytherapy devices, today announced that it has received a response from the FDA to its pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 (Y-90) RadioGel(tm) patented brachytherapy cancer product....

2014-02-14 23:24:38

The latest state-of-the-art linear accelerator at the Breast Health Center at Claxton-Hepburn Medical Center will provide a precise, effective way of delivering radiation therapy directly to cancer—right down to the millimeter. Ogdensburg, NY (PRWEB) February 14, 2014 Radiation therapy, a popular, safe method for eradicating cancer cells that may be still be present after surgery, plays an important role in treating all stages of breast cancer. Traditional radiation therapy uses...

2014-01-15 08:27:48

KENNEWICK, Wash., Jan. 15, 2014 /PRNewswire/ -- Advanced Medical Isotope Corporation ("AMIC") (OTCBB: ADMD), a company engaged in the development, production and distribution of medical isotopes focused on yttrium-90 brachytherapy devices, today announced that its CEO, James C. Katzaroff, will present AMIC's corporate overview at "TEN;" Noble Financial Capital Markets' Tenth Annual Equity Conference at Club Med in Sandpiper Bay, Florida, on Wednesday, January 22, 2014 at 8:30am...

2014-01-06 12:29:05

PALO ALTO, Calif., Jan. 6, 2014 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR), a world leader in cancer treatment and X-ray imaging technology, is announcing the publication of its 2013 Annual Report. A PDF version of the Varian 2013 annual report is now available at:http://investors.varian.com/VarianAnnualReports. ABOUT VARIAN MEDICAL SYSTEMS Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for...

2013-12-26 08:23:23

Evangelische Kliniken Gelsenkirchen anticipates performance improvements across a wide range of cancers throughout the body GELSENKIRCHEN, Germany, Dec. 26, 2013 /PRNewswire/ -- On October 28, clinicians at Evangelische Kliniken Gelsenkirchen (Gelsenkirchen, Germany) launched a new era of radiation therapy speed and accuracy with their first Versa HD(TM) case, a 72-year-old female patient with advanced (metastatic) cancer. Because the patient had received her first few fractions on...

2013-12-18 12:25:34

Agreement secures full Elekta solution across the McLaren enterprise ATLANTA, Dec. 18, 2013 /PRNewswire/ -- The ability to effectively manage data across disparate health systems to help drive quality care will be a cornerstone for health systems of the future. Elekta is proud to announce today that it has joined forces with Michigan-based McLaren Health Care to launch MOSAIQ® oncology information system throughout McLaren's cancer network. This partnership will enable McLaren to...

2013-12-13 08:25:26

NEW YORK, Dec. 13, 2013 /PRNewswire/ -- The first Esteya® electronic brachytherapy system in the United States has been installed at New York's Memorial Sloan-Kettering Cancer Center. Esteya by Nucletron, an Elekta company, is a new approach for skin cancer treatment that relies on a small, high dose rate (HDR) X-ray source to apply high precision radiotherapy directly to the cancer site. "With support from Elekta, Memorial Sloan-Kettering will lead a multicenter clinical study...